Showing 1 - 2 results of 2 for search 'Stephanie Feutren‐Burton', query time: 0.02s Refine Results
  1. 1
    Identification and development of a subtype-selective allosteric AKT inhibitor suitable for clinical development

    Identification and development of a subtype-selective allosteric AKT inhibitor suitable for clinical development by Natalie Page, Mark Wappett, Colin R. O’Dowd, Martin O’Rourke, Gerald Gavory, Lixin Zhang, J. S. Shane Rountree, Linda Jordan, Oliver Barker, Hayley Gibson, Caroline Boyd, Stephanie Feutren-Burton, Estelle McLean, Graham Trevitt, Timothy Harrison

    Published 2022-09-01
    Get full text
    Article
  2. 2
    USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGF

    USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGF by Anamarija Jurisic, Pei‐Ju Sung, Mark Wappett, Julien Daubriac, Ian T. Lobb, Wei‐Wei Kung, Nyree Crawford, Natalie Page, Eamon Cassidy, Stephanie Feutren‐Burton, J. S. Shane Rountree, Matthew D. Helm, Colin R. O'Dowd, Richard D. Kennedy, Gerald Gavory, Aaron N. Cranston, Daniel B. Longley, Xavier Jacq, Timothy Harrison

    Published 2024-04-01
    Get full text
    Article

Search Tools: